Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1244]

Role of chemotherapy in the treatment of metastatic breast cancer patients

Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani

Role of chemotherapy in the treatment of metastatic breast cancer patients ( Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani )

Recent data on eribulin in metastatic breast cancer patients from SABCS 2018

Professor Chris Twelves and Dr Giampaolo Bianchini

Recent data on eribulin in metastatic breast cancer patients from SABCS 2018 ( Professor Chris Twelves and Dr Giampaolo Bianchini )

Axicabtagene Ciloleucel in patients with refractory large B Cell lymphoma

Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA

$Axicabtagene Ciloleucel in patients with refractory large B Cell lymphoma ( Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA )$

Results from RIALTO, blinatumomab for paediatric patients with B-cell precursor...

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

$Results from RIALTO, blinatumomab for paediatric patients with B-cell precursor relapsed/refractory ALL ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )$

AMG 330: an anti-CD33 bispecific T-Cell engager antibody construct in relapsed...

Prof Marion Subklewe - University of Munich, Munich, Germany

$AMG 330: an anti-CD33 bispecific T-Cell engager antibody construct in relapsed/refractory AML ( Prof Marion Subklewe - University of Munich, Munich, Germany )$

Researchers identify mutation that causes resistance to venetoclax in CLL...

Dr Piers Blombery - University of Melbourne, Melbourne, Australia

Researchers identify mutation that causes resistance to venetoclax in CLL patients ( Dr Piers Blombery - University of Melbourne, Melbourne, Australia )

Daratumumab increases PFS in patients with transplant-ineligible multiple...

Prof Thierry Facon - Hôpital Claude Huriez, Lille, France

Daratumumab increases PFS in patients with transplant-ineligible multiple myeloma ( Prof Thierry Facon - Hôpital Claude Huriez, Lille, France )

Resistance mechanisms to venetoclax in patients with progressive CLL

Dr Piers Blombery - University of Melbourne, Melbourne, Australia

Resistance mechanisms to venetoclax in patients with progressive CLL ( Dr Piers Blombery - University of Melbourne, Melbourne, Australia )

Rivaroxaban in high-risk ambulatory cancer patients receiving systemic therapy

Dr Alok Khorana - Cleveland Clinic, Cleveland, USA

Rivaroxaban in high-risk ambulatory cancer patients receiving systemic therapy ( Dr Alok Khorana - Cleveland Clinic, Cleveland, USA )

Patient treatment preferences in relapsed/refractory multiple myeloma

Dr Joseph Mikhael, Prof James Chim and Prof Evangelos Terpos

$Patient treatment preferences in relapsed/refractory multiple myeloma ( Dr Joseph Mikhael, Prof James Chim and Prof Evangelos Terpos )$

Landscape change with oral proteasome maintenance in multiple myeloma patients

Prof Maria-Victoria Mateos, Prof Wee Joo Chng, Prof Meral Beksac and Dr Sagar...

Landscape change with oral proteasome maintenance in multiple myeloma patients ( Prof Maria-Victoria Mateos, Prof Wee Joo Chng, Prof Meral Beksac and Dr Sagar Lonial )

Outcomes for patients with disease progression following CD19-specific CAR T...

Dr Victor Chow - Fred Hutchinson Cancer Research Centre, Seattle, USA

Outcomes for patients with disease progression following CD19-specific CAR T-cell therapy ( Dr Victor Chow - Fred Hutchinson Cancer Research Centre, Seattle, USA )

More from ecancer